When a phase III trial is done, the researchers examine the information and decide irrespective of whether the final results have medical worth. The prospective benefit of evaluating reductions in late-phase cancer is usually that it could shorten the period of a trial. There are 2 opportunity disadvantages to this https://shigesatot999mzm5.loginblogin.com/profile